⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8697710 | 0.82 | CA1 (0.44) | — | |
| SCHEMBL31368201 | 0.76 | — | — | |
| SCHEMBL11883878 | 0.76 | — | — | |
| SCHEMBL8468919 | 0.76 | — | — | |
| SCHEMBL3433357 | 0.76 | — | — | |
| SCHEMBL4591090 | 0.76 | — | — | |
| SCHEMBL8468227 | 0.71 | CA1 (0.40) | — | |
| SCHEMBL3523807 | 0.71 | CA1 (0.35) | — | |
| SCHEMBL4335791 | 0.70 | CA1 (0.50) | — | |
| SCHEMBL7492627 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200190034-A1 | Inhibitors of Base Excision Repair Activity and Therapeutic Methods Based Thereon | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2020-06-18 | — | — | US | claimed |
| EP-3664790-A1 | INHIBITORS OF BASE EXCISION REPAIR ACTIVITY AND THERAPEUTIC METHODS BASED THEREON | The Board of Trustees of the Leland Stanford Junior University (US) | 2020-06-17 | — | — | EP | claimed |
| WO-2019032563-A1 | INHIBITORS OF BASE EXCISION REPAIR ACTIVITY AND THERAPEUTIC METHODS BASED THEREON | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2019-02-14 | — | — | WO | claimed |
| US-20140309257-A1 | TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USE AS THERAPEUTIC AGENTS | UNITED STATES GOVERNMENT | 2014-10-16 | — | — | US | claimed |
| WO-2013071306-A1 | TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USE AS THERAPEUTIC AGENTS | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2013-05-16 | — | — | WO | claimed |
| EP-0592676-B1 | IMINOSULFONYLUREA DERIVATIVE AND HERBICIDE | NISSAN CHEMICAL IND LTD (JP) | 1998-09-30 | — | — | EP | claimed |
| US-4956163-A | REACTING A PYROPHOSPHATE ION AND A SULFAMIDE | MONSANTO COMPANY (US) | 1990-09-11 | — | — | US | claimed |
| US-4946662-A | REACTING SULFAMIDES AND PHOSPHATE IONS IN PH BETWEEN 8 AND 10 | MONSANTO COMPANY (US) | 1990-08-07 | — | — | US | claimed |
| JP-5097615-A | — | — | None | — | — | JP | disclosed |
| EP-3656763-B1 | METHODS OF PREPARING TECOVIRIMAT | SIGA TECH INC (US) | 2025-12-17 | — | — | EP | disclosed |
| US-12234225-B2 | IL-17 ligands and uses thereof | DICE ALPHA, INC. (US) | 2025-02-25 | — | — | US | disclosed |
| CN-113874080-B | IL-17A modulators and uses thereof | 戴斯阿尔法公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118255723-A | Preparation method and application of antigen and antibody for detecting nicosulfuron herbicide | 云南省烟草公司楚雄州公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-117304130-A | MCL-1 inhibitors | 吉利德科学公司 | 2023-12-29 | — | — | CN | disclosed |
| EP-0034462-A2 | Imidodisulfamide derivatives, their preparation and use in pharmaceutical compositions | SMITHKLINE BECKMAN CORPORATION (US) | 1981-08-26 | — | — | EP | disclosed |
| EP-0034462-A2 | Imidodisulfamide derivatives, their preparation and use in pharmaceutical compositions | SMITHKLINE BECKMAN CORPORATION (US) | 1981-08-26 | — | — | EP | disclosed |
| US-4172089-A | COMPLEMENT INHIBITOR TRI- OR HEXA-PHENYL ESTER INTERMEDIATES | AMERICAN CYANAMID COMPANY (US) | 1979-10-23 | — | — | US | disclosed |
| US-4117003-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-3948795-A | Method of low-temperature activation of peroxides | TOKAI DENKA KOGYO KABUSHIKI KAISHA (JA) | 1976-04-06 | — | — | US | disclosed |
| JP-H00597615-A | — | — | 0001-01-01 | — | — | JP | disclosed |